Precocious Puberty Diagnoses Spike, COVID-19 Pandemic, and Body Mass Index: Findings From a 4-year Study
- PMID: 37873499
- PMCID: PMC10590639
- DOI: 10.1210/jendso/bvad094
Precocious Puberty Diagnoses Spike, COVID-19 Pandemic, and Body Mass Index: Findings From a 4-year Study
Abstract
Context: Since the COVID-19 outbreak, the number of girls with suspected precocious puberty has increased.
Objective: To compare the incidence of idiopathic central precocious puberty (ICPP) during COVID-19 with that of the previous 4 years.
Methods: Anthropometric, biochemical, and radiological parameters were collected between January 2016 and June 2021 from 133 girls who met the Rapidly Progressive ICPP criteria (RP-ICPP).
Results: We found a higher incidence of RP-ICPP between March 2020 and June 2021 (group 2) compared with January 2016 through March 2020 (group 1) (53.5% vs 41.1%); 2021 showed the highest annual incidence (P < .05). Group 1 and group 2 differed in age at diagnosis (7.96 ± 0.71 vs 7.61 ± 0.94; P < .05), mean Tanner stage (2.86 ± 0.51 vs 2.64 ± 0; P < .05), and in the time between the appearance of thelarche and diagnosis (0.93 ± 0.75 vs 0.71 ± 0.62 years, P < .05). There was an increase in the number of girls aged <8 years in group 2 and a significantly higher number of girls aged >8 years was found in group 1 (42 in group 1 vs 20 in group 2, P < 0.05). Overall body mass index SD score showed higher values in group 2 (1.01 ± 1.23 vs 0.69 ± 1.15; P = .18), which spent an average of 1.94 ± 1.81 hours per day using electronic devices; 88.5% of this group stopped any physical activity.
Conclusions: A spike in new diagnoses of idiopathic (1.79-fold higher) and RP-CPP coincided with the COVID-19 pandemic. The incidence of RP-ICPP was 1.3-fold higher during COVID-19 with a trend toward an increase in body mass index SD score. The expanding use of digital devices and the reduction of daily physical activity represent possible risk factors.
Keywords: BMI-body mass index; COVID-19; precocious puberty; rapidly progressive idiopathic central precocious puberty (RP-ICPP); screen exposure.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.
Figures
Similar articles
-
Increased incidence of precocious and accelerated puberty in females during and after the Italian lockdown for the coronavirus 2019 (COVID-19) pandemic.Ital J Pediatr. 2020 Nov 4;46(1):165. doi: 10.1186/s13052-020-00931-3. Ital J Pediatr. 2020. PMID: 33148304 Free PMC article.
-
Assessing Psychiatric Evaluations in Premature Thelarche and Idiopathic Central Precocious Puberty Cases: Exploring Depression, Anxiety, Quality of Life, and Coping Challenges.Cureus. 2024 Aug 29;16(8):e68123. doi: 10.7759/cureus.68123. eCollection 2024 Aug. Cureus. 2024. PMID: 39347161 Free PMC article.
-
Sedentary lifestyle and precocious puberty in girls during the COVID-19 pandemic: an Italian experience.Endocr Connect. 2022 Feb 14;11(2):e210650. doi: 10.1530/EC-21-0650. Endocr Connect. 2022. PMID: 35029543 Free PMC article.
-
Impacts of the COVID-19 pandemic on the diagnosis of idiopathic central precocious puberty in pediatric females in New York City.J Pediatr Endocrinol Metab. 2023 May 1;36(6):517-522. doi: 10.1515/jpem-2022-0628. Print 2023 Jun 27. J Pediatr Endocrinol Metab. 2023. PMID: 37114861 Review.
-
Implicating factors in the increase in cases of central precocious puberty (CPP) during the COVID-19 pandemic: Experience of a tertiary centre of pediatric endocrinology and review of the literature.Front Endocrinol (Lausanne). 2022 Nov 30;13:1032914. doi: 10.3389/fendo.2022.1032914. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531478 Free PMC article. Review.
Cited by
-
Central Precocious Puberty During the COVID-19 Pandemic Period: A Systematic Review of Literature.Cureus. 2024 Oct 7;16(10):e71002. doi: 10.7759/cureus.71002. eCollection 2024 Oct. Cureus. 2024. PMID: 39507164 Free PMC article. Review.
-
Precocious puberty, pandemic and beyond.Pituitary. 2024 Jul 26. doi: 10.1007/s11102-024-01434-8. Online ahead of print. Pituitary. 2024. PMID: 39060817 Review.
-
A Short-Duration Gonadotropin-Releasing Hormone Stimulation Test for the Diagnosis of Central Precocious Puberty.Medicina (Kaunas). 2023 Dec 22;60(1):24. doi: 10.3390/medicina60010024. Medicina (Kaunas). 2023. PMID: 38256285 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous